Overview
Curebase is a specialized clinical trial platform designed to facilitate decentralized (DCT) and hybrid study models. In the 2026 market landscape, Curebase distinguishes itself through a dual-layered technical architecture: a high-performance SaaS suite for data collection and a virtual site management layer. The platform solves the 'geographic bottleneck' in clinical research by enabling patients to participate from home or local clinics via 21 CFR Part 11-compliant tools. Its technical core integrates ePRO (Electronic Patient-Reported Outcomes), eCOA (Electronic Clinical Outcome Assessment), and multimedia eConsent workflows with a robust telehealth module. Strategically, Curebase operates as both a software provider and a decentralized site, providing the infrastructure needed for real-world evidence (RWE) generation and diverse patient recruitment. By automating the data flow between remote participants and principal investigators, it significantly reduces study timelines and increases the fidelity of longitudinal data in therapeutic areas ranging from rare diseases to digital therapeutics.